Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2024-08-05

Clinical Trial Update: NiteCAPP_HELPS_WD: Improving Sleep and Reducing Opioid Use in Chronic Pain Patients [NA]

View source ↗

Summary

The NiteCAPP_HELPS_WD trial assessing sleep improvement and opioid-use reduction in chronic pain patients with chronic insomnia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Missouri-Columbia | Conditions: Chronic Pain, Chronic Insomnia | NA | Status: WITHDRAWN